Skip to main content

Utility of Consortia Advocacy — A Conversation with Heather J. Blankinship [Podcast]

Utility of Consortia Advocacy — A Conversation with Heather J. Blankinship [Podcast]
Thursday, April 25, 2024

This week I discuss with my colleague, Heather Blankinship, Senior Scientist/Regulatory Consultant for B&C and The Acta Group, and Senior Manager for B&C® Consortia Management, L.L.C. (BCCM) to discuss the value of coalition advocacy, and its essentiality in the chemical space, especially now.

Heather manages many chemical coalitions and does a masterful job of managing issues and people. When you think about it, engaging commercial competitors to align on advocacy involving critically important regulatory, testing, and science policy issues is daunting. It involves strong communication skills, strong people skills, a keen understanding of the substantive issues, and endless patience. Heather explains how she does what she does, extolls the virtues of consortia advocacy, discusses some of BCCM’s successes, and explains why she and BCCM are as busy as they are these days.

©2024 Bergeson & Campbell, P.C.